Jonathan Fassberg Overview
- Company
- Solebury Trout
- Primary Position
-
Co-Chief Executi...
- Primary Industry
-
Healthcare
- Med. Deal Size
-
Jonathan Fassberg General Information
Biography
Mr. Jonathan Fassberg serves as Partner at Cancer Focus Fund. Mr. Jonathan Fassberg served as Co-Chief Executive Officer at Solebury Trout. Mr. Fassberg is the Founder and served as Chief Executive Officer at The Trout Group. He serves as the Vice-Chairman of Healthcare Investment Banking at Oppenheimer & Co. Inc. He serves as a Board Member at Calyxt. He also serves as a Venture Advisor at Israel Biotech Fund. He served as Chief Executive Officer at Trout Capital. He is a visionary entrepreneur who recognized early in his 20-year career that small-cap biotechnology companies were underserved in an investor relations capacity. To fill this void, Mr. Fassberg founded The Trout Group, the leading investor relations firm in the life sciences industry, and serves as Chief Executive Officer. Trout has served over 250 public and private companies from its six offices around the world. Trout's clients also had challenges accessing capital, leading Mr. Fassberg to start Trout Group's sister company, Trout Capital LLC, in 2004 to assist clients in a financial advisory role. Prior to founding Trout in 1996, Jonathan was a sell-side analyst at a healthcare-focused investment bank. Before his career on Wall Street, Jonathan spent four years at DuPont Pharmah in various sales and marketing positions. Jonathan holds a Bachelor of Science degree in biology and chemistry from The University of North Carolina - Chapel Hill and a Master of Business Administration degree in finance from New York University's Stern School of Business. He also holds Series 7, 24, 79 and 63 securities licenses.
Contact Information
Address
- Haogen B, 4 Oppenheimer Street
- Rehovot 7670104
- Israel
Jonathan Fassberg Positions (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
Cancer Focus Fund | Investor | Partner | Shreveport, LA | Venture Capital |
Jonathan Fassberg Lead Partner on Deals (1)
Jonathan Fassberg has been the lead partner on 1 deal. Their latest deal was with Cellevolve, a drug discovery company. The deal was made for on 18-Nov-2021.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Cellevolve | 18-Nov-2021 | Seed Round | Completed | Drug Discovery | San Francisco, CA |
Jonathan Fassberg Network (18)
Board Members (10)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Christopher Neugent | Calyxt | Calyxt | Roseville, MN | |
Laurent Arthaud | Calyxt | Cellectis | Roseville, MN | |
Calyxt | Calyxt | Roseville, MN | ||
Calyxt | Self | Roseville, MN | ||
Calyxt | Self | Roseville, MN |
Portfolio Executives (8)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Philip Vorhies | Cellevolve | Chief Business Officer & Chief Operating Officer | 18-Nov-2021 | San Francisco, CA |
Aston Ying | Cellevolve | Chief Data Officer | 18-Nov-2021 | San Francisco, CA |
Cellevolve | Chief External Affairs Officer | 18-Nov-2021 | San Francisco, CA | |
Cellevolve | Head of Finance & Senior Vice President of Finance | 18-Nov-2021 | San Francisco, CA | |
Cellevolve | Advisor | 18-Nov-2021 | San Francisco, CA |
Jonathan Fassberg Advisory Roles (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
Israel Biotech Fund | Investor | Venture Advisor | Rehovot, Israel | Venture Capital |
Jonathan Fassberg FAQs
-
Who is Jonathan Fassberg?
Mr. Jonathan Fassberg serves as Partner at Cancer Focus Fund.
-
How much does Jonathan Fassberg typically invest?
Jonathan Fassberg's median deal size is
. -
What is Jonathan Fassberg’s main position?
Jonathan Fassberg’s primary position is Co-Chief Executive Officer.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »